Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on February 12, 2026. The filing reports the extension of the company's termination date for consummating its initial business combination.
Key Financial Metrics
- Extension Payment: $34,330.96 deposited into the trust account.
- Promissory Note Issued: $34,330.96 principal amount.
- Contributors: Aimei Health Ltd (Sponsor) and United Hydrogen Group Inc. contributed equally ($17,165.48 each).
- Interest Rate: 0% (Non-interest bearing).
- Conversion Price: $10.00 per private unit (one ordinary share and one right).
Material Changes
The company extended its termination date from February 6, 2026, to March 6, 2026. This represents the fifteenth extension permitted under the company's Amended and Restated Articles of Association. The extension was funded by the issuance of an unsecured promissory note to the Sponsor and United Hydrogen Group Inc.
Outlook, Risks, and Contingencies
The promissory note becomes due and payable upon the consummation of a business combination with United Hydrogen Group Inc. The payees have the option, but not the obligation, to convert the note into private units immediately prior to the closing of the business combination. The filing does not provide specific guidance on the likelihood of the business combination closing or other operational risks beyond the extension mechanics.
Investor Verification Checklist
- Verify the status of the proposed business combination with United Hydrogen Group Inc.
- Confirm the total number of outstanding public shares to validate the $34,330.96 extension calculation.
- Review the full text of the Promissory Note (Exhibit 10.1) for additional covenants or conditions.
- Monitor the company's ability to secure further extensions if the business combination is not completed by March 6, 2026.